Geetha P. Bansal
Geetha P. Bansal
Unknown affiliation
Verified email at nih.gov
Title
Cited by
Cited by
Year
New use of BCG for recombinant vaccines
CK Stover, VF De La Cruz, TR Fuerst, JE Burlein, LA Benson, LT Bennett, ...
Nature 351 (6326), 456-460, 1991
15951991
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus
S Johnson, C Oliver, GA Prince, VG Hemming, DS Pfarr, SC Wang, ...
Journal of Infectious Diseases 176 (5), 1215-1224, 1997
6361997
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
CK Stover, GP Bansal, MS Hanson, JE Burlein, SR Palaszynski, JF Young, ...
The Journal of experimental medicine 178 (1), 197-209, 1993
3221993
Candidate recombinant vaccine for human B19 parvovirus
GP Bansal, JA Hatfield, FE Dunn, AA Kramer, F Brady, CH Riggin, ...
Journal of Infectious Diseases 167 (5), 1034-1044, 1993
1411993
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
SJ Rosenfeld, K Yoshimoto, S Kajigaya, S Anderson, NS Young, A Field, ...
The Journal of clinical investigation 89 (6), 2023-2029, 1992
1341992
Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta.
SM Wahl, DA Hunt, G Bansal, N McCartney-Francis, L Ellingsworth, ...
The Journal of experimental medicine 168 (4), 1403-1417, 1988
1071988
Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a …
R Edelman, K Palmer, KG Russ, HP Secrest, JAL Becker, SA Bodison, ...
Vaccine 17 (7-8), 904-914, 1999
811999
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
M Robert-Guroff, K Aldrich, R Muldoon, TL Stern, GP Bansal, TJ Matthews, ...
Journal of virology 66 (6), 3602-3608, 1992
801992
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles
R Kumar, PC Ray, D Datta, GP Bansal, E Angov, N Kumar
Vaccine 33 (39), 5064-5071, 2015
742015
MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma
M Dang, JT Lysack, T Wu, TW Matthews, SP Chandarana, NT Brockton, ...
American Journal of Neuroradiology 36 (1), 166-170, 2015
562015
Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis.
T Kamradt, B Lengl-Janssen, AF Strauss, G Bansal, AC Steere
Infection and immunity 64 (4), 1284-1289, 1996
561996
Use of recombinant BCG as a vaccine delivery vehicle
CK Stover, VF De la Cruz, GP Bansal, MS Hanson, TR Fuerst, WR Jacobs, ...
Advances in experimental medicine and biology, 175-182, 1992
471992
Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission
G Pantaleo, JF Demarest, M Vaccarezza, C Graziosi, GP Bansal, ...
European journal of immunology 25 (1), 226-231, 1995
421995
Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances.
GP Bansal, A Malaspina, J Flores
Current opinion in molecular therapeutics 12 (1), 39-46, 2010
332010
A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 …
GP Bansal
Biologicals 35 (4), 367-371, 2007
282007
Protective immunity elicited by rBCG vaccines.
CK Stover, GP Bansal, S Langerman, MS Hanson
Developments in biological standardization 82, 163-170, 1994
251994
Suppression of bacterial cell wall-induced polyarthritis by recombinant gamma interferon
JB Allen, GP Bansal, GM Feldman, AO Hand, LM Wahl, SM Wahl
Cytokine 3 (2), 98-106, 1991
231991
Efficacy and safety of live recombinant BCG vaccines.
MS Hanson, GP Bansal, S Langermann, CK Stover, I Orme
Developments in biological standardization 84, 229-236, 1995
221995
Potent functional immunogenicity of Plasmodium falciparum transmission-blocking antigen (Pfs25) delivered with nanoemulsion and porous polymeric nanoparticles
R Kumar, G Ledet, R Graves, D Datta, S Robinson, GP Bansal, T Mandal, ...
Pharmaceutical research 32 (12), 3827-3836, 2015
212015
HIV/AIDS vaccines: a need for new concepts?
MP Girard, GP Bansal
International reviews of immunology 27 (6), 447-471, 2008
192008
The system can't perform the operation now. Try again later.
Articles 1–20